Constellation Brands (STZ) Up 22.9% Since Last Earnings Report: Can It Continue?

Constellation Brands’ fiscal Q2 2027 comparable EPS was $3.74, up 3% year over year and above the $3.62 consensus; sales rose 6% to $2.63 billion, also beating estimates. Margins were pressured, with comparable operating margin down 160 bps to 34.1%, and analyst estimates have trended lower despite shares gaining 22.9% in the month after earnings. The company reaffirmed comparable EPS guidance of $11.20-$11.90, raised reported EPS guidance to $11.85-$12.55, declared a $1.03 quarterly dividend, and acquired SpikedAde for $75 million plus up to $278 million in contingent consideration.

Analysis

The key signal is the gap between shipments and consumer takeaway: beer shipments grew while depletions slipped. That may reflect timing or distributor inventory rather than durable demand; if the gap persists, future shipments could undershoot even as reported revenue currently looks healthy. Verify distributor inventories and whether depletions stabilize before treating shipment growth as a trend. Core-brand weakness also matters more than headline share gains if growth from smaller brands cannot sustain mix and marketing costs.

The 22.9% rally has raised the bar while organic-sales guidance remains around flat and fresh estimates are moving lower. That price/estimate divergence leaves STZ vulnerable to a reaction-function reset at the next earnings report, particularly if management protects share with marketing and margins fail to recover. Near term, momentum can persist if retail takeaway improves; over 1–3 months, depletion trends and estimate revisions are the more relevant catalysts. Over 6–18 months, successful RTD distribution could add an option on growth, but the contingent payment is performance-linked and does not establish near-term earnings contribution.

Contrarian point: this is not yet a clean short. Cash generation and category share gains provide support, and a shipment/depletion mismatch can reverse. Treat the rally as a reason to tighten risk, not proof of an imminent downturn. The thesis weakens if beer depletions turn positive and margins track guidance without further estimate cuts.

Key Decisions for Investors

• Avoid chasing STZ after the sharp rally; consider trimming overweight exposure pending evidence that beer depletions—not just shipments—are recovering.
• For a tactical bearish expression, evaluate a defined-risk STZ put spread into the next earnings catalyst only if option pricing is reasonable; cap premium at risk and avoid an outright short absent confirmation.
• Track quarterly shipment-versus-depletion trends, distributor inventory commentary, beer operating margin, and analyst estimate revisions. Persistent positive shipment/depletion divergence or another margin shortfall would strengthen the downside case.
• Reassess the bearish stance if depletions return to growth, management delivers margins within guidance, and estimate revisions stabilize; those would indicate the rally is being supported by underlying demand rather than positioning alone.